Navigating the GLP-1 Gray Market: Access, Affordability, and Safety in 2025
High demand and limited coverage have pushed some to gray-market GLP-1s. Learn the risks, legal context, safer access routes, and cost strategies.
Discover articles related to zepbound
High demand and limited coverage have pushed some to gray-market GLP-1s. Learn the risks, legal context, safer access routes, and cost strategies.
Tirzepatide (Zepbound) is now FDA-approved for OSA. Trial outcomes, who qualifies, and how to use alongside CPAP and lifestyle.

Late-stage trials suggest tirzepatide can significantly improve obstructive sleep apnea metrics. How to identify candidates and measure benefit.
Learn how to use tirzepatide (Mounjaro/Zepbound) effectively for weight loss and diabetes management. Complete dosing, administration, and optimization guide.

Compare semaglutide and tirzepatide for weight loss and diabetes management. Expert analysis of effectiveness, side effects, and cost.